Working… Menu
Trial record 6 of 15 for:    "Depressive Disorder" [DISEASE] AND Behavioral | ( Map: Latvia )

Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 18 Years of Age

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02871297
Recruitment Status : Enrolling by invitation
First Posted : August 18, 2016
Last Update Posted : November 29, 2018
Information provided by (Responsible Party):
H. Lundbeck A/S

No Study Results Posted on for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : September 2019
Estimated Study Completion Date : September 2019